Prostate-specific antigen screening can be beneficial to younger and at-risk men

In 2008, the United States Preventive Services Task Force issued guidelines recommending against screening for prostate-specific antigen (PSA) in men aged 75 years or older. They concluded that there was insufficient evidence as to the benefits and harms of screening in younger men. The task force